[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Ocular Drug Delivery Market Report 2017

December 2017 | 99 pages | ID: U51D18FAFD8EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Ocular Drug Delivery in these regions, from 2012 to 2022 (forecast).
United States Ocular Drug Delivery market competition by top manufacturers/players, with Ocular Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • OCULAR THERAPEUTIX, INC
  • Alimera Sciences
  • Allergan, Plc
  • EyeGate Pharma
  • Valeant Pharmaceuticals International, Inc
  • Envisia Therapeutics
  • Clearside Biomedical
  • Graybug Vision Inc
  • Taiwan Liposome Company
  • Santen Pharmaceutical Co., Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Technology
    • Ocular Insert
    • Iontophoresis
    • Intraocular Implants
    • In Situ Gel & Punctal Plugs
    • Others
  • By Form
    • Solution
    • Suspension
    • Emulsion
    • Liposomes & Nanoparticles
    • Ointment
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics
  • Homecare Settings
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Ocular Drug Delivery Market Report 2017

1 OCULAR DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Ocular Drug Delivery
1.2 Classification of Ocular Drug Delivery by Product Category
  1.2.1 United States Ocular Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ocular Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Ocular Insert
  1.2.4 Iontophoresis
  1.2.5 Intraocular Implants
  1.2.6 In Situ Gel & Punctal Plugs
  1.2.7 Others
1.3 United States Ocular Drug Delivery Market by Application/End Users
  1.3.1 United States Ocular Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Ophthalmic Clinics
  1.3.5 Homecare Settings
1.4 United States Ocular Drug Delivery Market by Region
  1.4.1 United States Ocular Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ocular Drug Delivery Status and Prospect (2012-2022)
  1.4.3 Southwest Ocular Drug Delivery Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ocular Drug Delivery Status and Prospect (2012-2022)
  1.4.5 New England Ocular Drug Delivery Status and Prospect (2012-2022)
  1.4.6 The South Ocular Drug Delivery Status and Prospect (2012-2022)
  1.4.7 The Midwest Ocular Drug Delivery Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ocular Drug Delivery (2012-2022)
  1.5.1 United States Ocular Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 United States Ocular Drug Delivery Revenue and Growth Rate (2012-2022)

2 UNITED STATES OCULAR DRUG DELIVERY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ocular Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ocular Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ocular Drug Delivery Average Price by Players/Suppliers (2012-2017)
2.4 United States Ocular Drug Delivery Market Competitive Situation and Trends
  2.4.1 United States Ocular Drug Delivery Market Concentration Rate
  2.4.2 United States Ocular Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ocular Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OCULAR DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ocular Drug Delivery Sales and Market Share by Region (2012-2017)
3.2 United States Ocular Drug Delivery Revenue and Market Share by Region (2012-2017)
3.3 United States Ocular Drug Delivery Price by Region (2012-2017)

4 UNITED STATES OCULAR DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ocular Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
4.3 United States Ocular Drug Delivery Price by Type (2012-2017)
4.4 United States Ocular Drug Delivery Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OCULAR DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ocular Drug Delivery Sales and Market Share by Application (2012-2017)
5.2 United States Ocular Drug Delivery Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OCULAR DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 OCULAR THERAPEUTIX, INC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ocular Drug Delivery Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alimera Sciences
  6.2.2 Ocular Drug Delivery Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Allergan, Plc
  6.3.2 Ocular Drug Delivery Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 EyeGate Pharma
  6.4.2 Ocular Drug Delivery Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Valeant Pharmaceuticals International, Inc
  6.5.2 Ocular Drug Delivery Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Envisia Therapeutics
  6.6.2 Ocular Drug Delivery Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Clearside Biomedical
  6.7.2 Ocular Drug Delivery Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Graybug Vision Inc
  6.8.2 Ocular Drug Delivery Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Taiwan Liposome Company
  6.9.2 Ocular Drug Delivery Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Santen Pharmaceutical Co., Ltd
  6.10.2 Ocular Drug Delivery Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Ocular Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ocular Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ocular Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OCULAR DRUG DELIVERY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ocular Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ocular Drug Delivery Sales Volume Forecast by Type (2017-2022)
11.3 United States Ocular Drug Delivery Sales Volume Forecast by Application (2017-2022)
11.4 United States Ocular Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Ocular Drug Delivery
Figure United States Ocular Drug Delivery Market Size (K Doses) by Type (2012-2022)
Figure United States Ocular Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Ocular Insert Product Picture
Figure Iontophoresis Product Picture
Figure Intraocular Implants Product Picture
Figure In Situ Gel & Punctal Plugs Product Picture
Figure Others Product Picture
Figure United States Ocular Drug Delivery Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Ocular Drug Delivery by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Ophthalmic Clinics Examples
Table Key Downstream Customer in Ophthalmic Clinics
Figure Homecare Settings Examples
Table Key Downstream Customer in Homecare Settings
Figure United States Ocular Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure The West Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Ocular Drug Delivery Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Ocular Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ocular Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States Ocular Drug Delivery Sales Share by Players/Suppliers
Figure United States Ocular Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ocular Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ocular Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ocular Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States Ocular Drug Delivery Revenue Share by Players/Suppliers
Table United States Market Ocular Drug Delivery Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Ocular Drug Delivery Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Ocular Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States Ocular Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ocular Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ocular Drug Delivery Product Category
Table United States Ocular Drug Delivery Sales (K Doses) by Region (2012-2017)
Table United States Ocular Drug Delivery Sales Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Sales Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Sales Market Share by Region in 2016
Table United States Ocular Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ocular Drug Delivery Revenue Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Revenue Market Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Revenue Market Share by Region in 2016
Table United States Ocular Drug Delivery Price (USD/Dose) by Region (2012-2017)
Table United States Ocular Drug Delivery Sales (K Doses) by Type (2012-2017)
Table United States Ocular Drug Delivery Sales Share by Type (2012-2017)
Figure United States Ocular Drug Delivery Sales Share by Type (2012-2017)
Figure United States Ocular Drug Delivery Sales Market Share by Type in 2016
Table United States Ocular Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ocular Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Type in 2016
Table United States Ocular Drug Delivery Price (USD/Dose) by Types (2012-2017)
Figure United States Ocular Drug Delivery Sales Growth Rate by Type (2012-2017)
Table United States Ocular Drug Delivery Sales (K Doses) by Application (2012-2017)
Table United States Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Ocular Drug Delivery Sales Market Share by Application in 2016
Table United States Ocular Drug Delivery Sales Growth Rate by Application (2012-2017)
Figure United States Ocular Drug Delivery Sales Growth Rate by Application (2012-2017)
Table OCULAR THERAPEUTIX, INC Basic Information List
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Allergan, Plc Basic Information List
Table Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table EyeGate Pharma Basic Information List
Table EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International, Inc Basic Information List
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Envisia Therapeutics Basic Information List
Table Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Clearside Biomedical Basic Information List
Table Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Graybug Vision Inc Basic Information List
Table Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Taiwan Liposome Company Basic Information List
Table Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Santen Pharmaceutical Co., Ltd Basic Information List
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Growth Rate (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Market Share in United States (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Figure Manufacturing Process Analysis of Ocular Drug Delivery
Figure Ocular Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Ocular Drug Delivery Major Players/Suppliers in 2016
Table Major Buyers of Ocular Drug Delivery
Table Distributors/Traders List
Figure United States Ocular Drug Delivery Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ocular Drug Delivery Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Type in 2022
Table United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Application in 2022
Table United States Ocular Drug Delivery Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Ocular Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ocular Drug Delivery Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories